Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 121,433 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Brain Tumors
Interventions: temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 6 Months to 21 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2017
U.S. locations: 16
States / cities: Phoenix, Arizona • Atlanta, Georgia • Lihue, Hawaii + 13 more

Conditions: Candidates for BRCA 1/2 Genetic Testing
Interventions: Genetic Providers, Visual Aids, Post-Disclosure Asessments, In-person Clinical Follow-Up, 6 Month and 12 Month Assessments; Genetic · Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 289 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 5
States / cities: Chicago, Illinois • Camden, New Jersey • Philadelphia, Pennsylvania

Conditions: Osteo Arthritis Knee
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: Florida State University; Other
Eligibility: 50 Years to 85 Years
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cataract
Interventions: Softec HD IOL; Device
Lead sponsor: Lenstec Incorporated; Industry
Eligibility: 40 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: Phoenix, Arizona • Fort Myers, Florida • Rome, Georgia

Conditions: Pneumonia, Ventilator Associated Pneumonia
Interventions: Lactobacillus GG, placebo; Dietary Supplement
Lead sponsor: Creighton University; Other
Eligibility: 19 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Major Depressive Disorder, Insulin Resistance
Interventions: Pioglitazone, Sugar Pill; Drug
Lead sponsor: Stanford University; Other
Eligibility: 20 Years to 65 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Restenosis, Peripheral Vascular Disease
Interventions: JetStream Navitus; Device
Lead sponsor: Midwest Cardiovascular Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Bettendorf, Iowa • Dallas, Texas

Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Interventions: Pegcetacoplan; Drug
Lead sponsor: Apellis Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 7
States / cities: Los Angeles, California • Miami Lakes, Florida • Louisville, Kentucky + 4 more

Conditions: Pre Eclampsia
Interventions: Sphygmo: Automatic Blood Pressure Monitor, GE Dinamap ProCare Automatic Blood Pressure Monitor; Device
Lead sponsor: William Marsh Rice University; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pancreatic Adenocarcinoma, Pancreatic Cancer
Interventions: AdV-tk, Valacyclovir; Biological · Drug
Lead sponsor: Candel Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 3
States / cities: Duarte, California • La Jolla, California • Columbus, Ohio

Conditions: Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects
Interventions: TD-3504, 15N2-tofacitinib, Placebo; Drug
Lead sponsor: Theravance Biopharma; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Anaheim, California

Conditions: Vascular Diseases, Surgery
Interventions: Protein-Calorie Restriction; Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Mandibular Fractures
Interventions: Control group without use of VSP, Treatment Group with use of VSP; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Smoking
Interventions: Nicoderm Transdermal Patch, Nicotine Nasal Spray; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 75 Years
Enrollment: 674 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Locally Advanced or Metastatic Solid Carcinomas, Colon Cancer, Cholangiocarcinoma
Interventions: TRK-950; Biological
Lead sponsor: Toray Industries, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Phoenix, Arizona • Scottsdale, Arizona

Conditions: Oxygen Saturation Measurement
Interventions: Philips FAST SpO2 with Nellcor Pulse Oximetry Sensors; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Dementia, Nutrition Poor
Interventions: Transitional-state food therapeutic nutrition supplement; Dietary Supplement
Lead sponsor: University of Oregon; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Eugene, Oregon • Portland, Oregon

Conditions: Rectal Cancer
Interventions: CT Virtual Proctoscopy (CTVP); Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Malignant Solid Tumour, Hematologic Malignancies, Planned Hematopoietic Cell Transplantation
Interventions: Physical performance testing and patient-generated health data; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Breast Cancer, Hot Flashes
Interventions: acupuncture therapy, hot flashes attenuation, management of therapy complications; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2007
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostate Cancer
Interventions: brachytherapy, iodine I 125, radiation therapy; Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years to 120 Years · Male only
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2013
U.S. locations: 236
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 184 more

Conditions: Ulcerative Colitis
Interventions: Mirikizumab, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 249 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 11
States / cities: Chula Vista, California • La Jolla, California • Rialto, California + 8 more

Conditions: Rhytides
Interventions: Clay mask; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 50 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Iron Deficiency
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 1,820 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study

Self-Administered Transcranial Direct Current Stimulation for Pain in Older Adults With Knee Osteoarthritis

Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL

Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia

Pioglitazone in Patients With Mood Disorders

JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers

AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)

TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)

Dietary Restriction in Vascular Surgery

Comparison of Operating Room Time Length With the Use of Virtual Surgical Planning Versus Conventional Treatment of Mandible Fractures

Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

Philips FAST Evaluation

Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks

CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer

Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation

Acupuncture in Treating Hot Flashes in Women With Breast Cancer

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

The Cosmetic Effect of Mineral Clay Masks

Iron Replacement in Blood Donors